T-Lymphocytic Leukemia, Acute
1 clinical trials · Condition
◉ Watch T-Lymphocytic Leukemia, Acute
| Record | Firm | Date |
|---|---|---|
| Daratumumab in VHR T-ALL Treated According to the ALL National Treatment Program (NCT06253637) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2024-10-17 |
Track T-Lymphocytic Leukemia, Acute automatically
Every clearance here is in the API, with alerts when new ones post.